The complexity and size of clinical trials has increased dramatically in parallel with growing costs and mounting regulatory pressures. The introduction of the finalized International Council for Harmonization s (ICH) addendum to the ICH E6 Guideline for Good Clinical Practice (ICH E6 R2) earlieOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.